Private Investment Mandates

Deploy capital into high-growth cannabis markets before they become crowded.

ISC structures bespoke investment mandates for capital allocators seeking early access to public and private cannabis opportunities across the Global South.

Government-backed projects Private operators Deal flow from $2M to $200M+

Private Mandate first. Nexus supports the intelligence layer, while ISC structures sourcing, screening, stakeholder access and mandate execution.

Why Cannabis, Why Now

Cannabis is becoming a strategic asset class in emerging regulated markets.

Across the Global South, cannabis is moving from informal demand to regulated healthcare, agriculture, wellness, technology, tourism and industrial opportunity. The capital layer is still early, fragmented and relationship-driven.

Regulation

Regulation is opening investable categories

New frameworks create demand for licensed operators, compliant infrastructure, medical access, processing capacity, distribution, testing, technology and advisory support.

Access

The best opportunities are not always public

Many serious opportunities emerge through policy conversations, operator needs, government priorities and early market formation before they appear in conventional deal channels.

Positioning

First movers can shape the market

Investors entering early can influence structure, partnerships, governance and positioning before institutional competition intensifies.

$33.5B → $148B Legal cannabis market growth toward 2030.
$2M–$200M+ Private mandate deal flow range.
Global South Caribbean, Africa, Latin America and emerging regulated markets.
Why ISC

We help investors see what is investable, who controls it and what must happen next.

ISC operates between governments, regulators, founders, operators, researchers and capital allocators. This gives investors more than a list of deals: it gives context, access and execution intelligence.

Government

Government proximity

Visibility on public-sector cannabis priorities, tender logic, market design needs and implementation gaps.

Regulation

Regulatory context

Understanding of the rules, bottlenecks and stakeholder dynamics that determine whether capital can enter safely.

Operators

Operator and founder network

Access to emerging operators, founders and ventures that need capital, partnerships, compliance support or market-entry structure.

Studio

Startup Studio pipeline

Early exposure to ventures and concepts across health, tourism, compliance, AI, education and cannabis-enabled services.

Nexus

Nexus intelligence layer

Signals from tenders, research feeds, market activity, media, professional networks and ISC's field intelligence.

Execution

Mandate execution support

Support for sourcing, screening, strategic fit, regulatory mapping, due diligence preparation and deal prioritization.

Core Offer

Private mandates for capital allocators with a $5M+ deployment horizon.

For investors who want active access to emerging cannabis markets, ISC structures tailored mandates based on geography, capital profile, target sectors, risk tolerance and execution capacity.

Investment thesis design

Define target markets, asset types, risk limits, expected role, time horizon and deployment logic.

Deal sourcing

Identify public and private opportunities across government-backed projects, operators, infrastructure and startups.

Regulatory mapping

Clarify which public bodies, advisors and compliance requirements shape each opportunity.

Due diligence support

Support first-pass screening, feasibility review, partner credibility and next-step requirements.

Pipeline targets

Where appropriate, ISC can scope a defined number of qualified opportunities over a set period.

Strategic introductions

Facilitate relevant introductions to operators, founders, regulators, advisors or co-investors.

Private mandates are scoped case by case. No public pricing. No generic package. Each mandate is designed around the investor's capital, thesis and target markets.
Powered by Nexus

Nexus helps surface the signals behind the mandate.

Nexus is ISC's intelligence layer. It helps track market movement, tenders, regulatory developments, operator signals, startup activity and opportunity patterns across cannabis markets.

Signals

Deal signals

Curated indicators around public mandates, private operators, tenders and emerging project needs.

Intelligence

Weekly intelligence

Structured visibility on what is changing across target markets, sectors and opportunity types.

Mapping

Opportunity mapping

Signals from tenders, research feeds, media sources, professional networks and ISC field intelligence.

Spotlight

Monthly Opportunity Spotlight

Selected opportunities with context on feasibility, regulatory status, market fit and next-step logic.

Explore Nexus Intelligence
Investment Areas

From infrastructure to market entry, cannabis opportunities are expanding beyond cultivation.

ISC private mandates can be scoped around a focused thesis or across multiple opportunity categories depending on the investor's deployment priorities.

Infrastructure

Infrastructure Expansion

Facilities for cultivation, processing, testing, logistics, compliant storage and medical supply chains.

Ventures

Innovation & Startups

Ventures building products and services across medical cannabis, AI, education, compliance, wellness and tourism.

Impact

Sustainable Growth

Eco-conscious farming, local economic development, circular production and community-aligned cannabis models.

Public Sector

Government-Supported Projects

Opportunities linked to national market design, tender needs, strategic pilots and implementation partners.

Operators

Private Operators

Licensed or license-seeking operators needing capital, strategic partners, compliance structure or market-entry support.

Platforms

Market Entry Platforms

Vehicles for entering regulated cannabis ecosystems through partnerships, distribution, medical access, tourism or research.

Market Impact

Shaping the future today.

These macro ambitions frame the long-term opportunity: regulated cannabis can affect healthcare access, innovation, research, education and startup creation.

50

Countries

Integrate cannabis medications into healthcare systems of 50 countries by 2030.

2.5

Billion People

Facilitate therapeutic benefits from cannabis for over 2.5 billion people suffering from chronic pain, neurological disorders, and glaucoma.

1,000

Research Projects

Invest in over 1,000 new research projects by 2035 to discover novel cannabis applications.

200

Patents Filed

Secure 200 new patents for cannabis-derived products and technologies by 2035.

100K

Youth Educated

Deliver cannabis education programs to 100,000 children by 2030.

80

Startups

Launch 80 cannabis-based startups by 2029, targeting underserved areas to boost local economies.

Private Capital

If you are serious about cannabis exposure in the Global South, start with a mandate conversation.

ISC works with investors who need more than market commentary. We help define the thesis, identify qualified opportunities, understand regulatory context and move toward serious execution.

ISC

© Copyright 2023 International Society of Cannabis. All rights reserved.

Scroll to Top